HomeRVMD • NASDAQ
add
Revolution Medicines Inc
Previous close
$76.32
Day range
$75.65 - $78.17
Year range
$29.17 - $78.17
Market cap
14.48B USD
Avg Volume
2.46M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 52.76M | 120.21% |
Net income | -305.21M | -95.28% |
Net profit margin | — | — |
Earnings per share | -1.61 | -71.28% |
EBITDA | -313.24M | -79.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.93B | 24.66% |
Total assets | 2.25B | 27.73% |
Total liabilities | 655.02M | 233.01% |
Total equity | 1.60B | — |
Shares outstanding | 193.32M | — |
Price to book | 9.06 | — |
Return on assets | -33.67% | — |
Return on capital | -42.00% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -305.21M | -95.28% |
Cash from operations | -207.31M | -58.96% |
Cash from investing | 24.85M | 215.74% |
Cash from financing | -1.59M | -102.06% |
Net change in cash | -184.05M | -146.74% |
Free cash flow | -121.28M | -51.86% |
About
Founded
2014
Headquarters
Website
Employees
809
